Gender, age at the first vaccination and age
Item
a male or female aged ≥ 15 years at the time of the first vaccination. in centre 103 (germany) and centre 1 (netherlands), only subjects ≥ 18 years will be enrolled.
boolean
C0079399 (UMLS CUI [1])
C0001779 (UMLS CUI [2,1])
C0419726 (UMLS CUI [2,2])
C0001779 (UMLS CUI [3])
Medical history and clinical examination
Item
free of obvious health problems as established by medical history and clinical examination before entering into the study.
boolean
C0262926 (UMLS CUI [1])
C1456356 (UMLS CUI [2])
Written informed consent
Item
written informed consent obtained from the subject and/or from the parent or guardian of the subject.
boolean
C0021430 (UMLS CUI [1])
Gynaecological status
Item
if the subject was a female, she was of non-childbearing potential, if of childbearing potential, she was abstinent or used adequate contraceptive precautions for one month prior to enrollment and up to two months after the last vaccination
boolean
C3831118 (UMLS CUI [1])
C0700589 (UMLS CUI [2])
Experimental drug
Item
use of any investigational or non-registered drug or vaccine other than the study vaccine (s) during the study period or within 30 days preceding the first dose of study vaccine.
boolean
C0304229 (UMLS CUI [1])
Planned vaccination beyond study protocol
Item
planned administration/ administration of a vaccine not foreseen by the study protocol during the period starting from 30 days before each dose of vaccine and ending 30 days after.
boolean
C0042196 (UMLS CUI [1,1])
C1301732 (UMLS CUI [1,2])
C0205101 (UMLS CUI [1,3])
C2348563 (UMLS CUI [1,4])
Hepatitis B vaccination
Item
previous vaccination against hepatitis b.
boolean
C0474232 (UMLS CUI [1])
Response to hepatitis B vaccination
Item
history of non-response to previous hepatitis b vaccination.
boolean
C0474232 (UMLS CUI [1,1])
C1548130 (UMLS CUI [1,2])
HBV exposure
Item
known exposure to hepatitis b virus within 6 weeks.
boolean
C0019169 (UMLS CUI [1,1])
C0332157 (UMLS CUI [1,2])
Hepatitis b infection
Item
history of hepatitis b infection.
boolean
C0019163 (UMLS CUI [1])
HIV infection
Item
confirmed human immunodeficiency virus (hiv) infection.
boolean
C0019693 (UMLS CUI [1])
Congenital or hereditary immunodeficiency
Item
a family history of congenital or hereditary immunodeficiency.
boolean
C0853602 (UMLS CUI [1])
Hypersensitivity to vaccine
Item
history of allergic disease or reactions likely to be exacerbated by any component of the vaccine.
boolean
C0020517 (UMLS CUI [1,1])
C0042210 (UMLS CUI [1,2])
Acute disease
Item
acute disease at the time of enrollment.
boolean
C0001314 (UMLS CUI [1])
Hepatomegaly, right upper quadrant abdominal pain or tenderness
Item
hepatomegaly, right upper quadrant abdominal pain or tenderness.
boolean
C0019209 (UMLS CUI [1])
C0235299 (UMLS CUI [2])
C0238571 (UMLS CUI [3])
Pharmacotherapy
Item
administration of immunoglobulins and/or any blood products within the three months preceding the first dose of study vaccine or planned administration/ administration during the study period.
boolean
C0021022 (UMLS CUI [1])
C0852255 (UMLS CUI [2])
C0042196 (UMLS CUI [3])
Gynaecological status
Item
pregnant or lactating female
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])